Progressive, atrophying, chronic granulomatous dermohypodermitis. Autoimmune disease?
D000328:Adult; D001284:Atrophy / Q000209:etiology; D001327:Autoimmune Diseases; D001365:Axilla / Q000473:pathology; D001379:Azathioprine / Q000627:therapeutic use; D001500:BCG Vaccine / Q000009:adverse effects*; D002908:Chronic Disease; D003483:Cutis Laxa / Q000188:drug therapy / Q000209:etiology; D003907:Dexamethasone / Q000627:therapeutic use; D003967:Diarrhea / Q000188:drug therapy; D006099:Granuloma / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D006689:Hodgkin Disease / Q000473:pathology; D006801:Humans; D007916:Lepromin / Q000009:adverse effects*; D008198:Lymph Nodes / Q000473:pathology; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D012871:Skin Diseases / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology
D001500:BCG Vaccine; D007916:Lepromin; D003907:Dexamethasone; D001379:Azathioprine; D011241:Prednisone